BNP Paribas China Equity vs UBS Lux Equity Fund Biotech USD

BNP Paribas China Equity vs UBS Lux Equity Fund Biotech USD

1. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    16

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 22 holdings in BNP Paribas China Equity, where the largest holding is Alibaba Group Holding Ltd (9.57), followed by Tencent (9.35) and Xiaomi (6.61). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in BNP Paribas China Equity and UBS Lux Equity Fund Biotech USD.

BNP Paribas China Equity UBS Lux Equity Fund Biotech USD
1. Alibaba Group Holding Ltd
China
9.57 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Tencent Holdings Ltd
China
9.35 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Xiaomi
China
6.61 %
3. Moderna Inc
9.21 %
4. Industrial and Commercial Bank of China Ltd Class H
China
4.22 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Pop Mart International Group Ltd
China
4.17 %
5. AbbVie Inc
USA
5.53 %
6. Meituan Class B
China
3.16 %
6. Gilead Sciences Inc
USA
4.66 %
7. Trip.com Group Ltd
Singapore
2.91 %
7. Amgen Inc
4.3 %
8. Ping An Insurance Co
China
2.71 %
8. BioNTech SE
4.13 %
9. NetEase ADR
China
2.41 %
9. Karuna Therapeutics Inc
3.75 %
10. KE Holdings Inc ADR
China
2.4 %
10. Royalty Pharma Plc
3.37 %
11. JD.com Inc
China
2.22 %
-
12. Taiwan Semiconductor Manufacturing Company
Taiwan
1.7 %
-
13. Pinduoduo Inc
China
1.68 %
-
14. China Yangtze Power Co Ltd Class A
China
1.64 %
-
15. BYD Co Ltd Class H
China
1.52 %
-
16. Sunny Optical Technology Company Ltd
China
1.27 %
-

The list of fund holdings was last updated on June 5, 2025.